DOCSLIB.ORG

83(R) Hb 1333

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

By:AAPerry, et al. H.B.ANo.A1333 Substitute the following forAH.B.ANo.A1333: By:AAHerrero C.S.H.B.ANo.A1333 A BILL TO BE ENTITLED 1 AN ACT 2 relating to the designation of certain synthetic compounds to 3 Penalty Group 2 or 2-A of the Texas Controlled Substances Act. 4 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: 5 SECTIONA1.AASections 481.002(5) and (6), Health and Safety 6 Code, are amended to read as follows: 7 (5)AA"Controlled substance" means a substance, 8 including a drug, an adulterant, and a dilutant, listed in 9 Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A, 10 3, or [through] 4. The term includes the aggregate weight of any 11 mixture, solution, or other substance containing a controlled 12 substance. 13 (6)AA"Controlled substance analogue" means: 14 (A)AAa substance with a chemical structure 15 substantially similar to the chemical structure of a controlled 16 substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or 17 2-A; or 18 (B)AAa substance specifically designed to produce 19 an effect substantially similar to, or greater than, the effect of a 20 controlled substance in Schedule I or II or Penalty Group 1, 1-A, 21 [or] 2, or 2-A. 22 SECTIONA2.AASection 481.103(a), Health and Safety Code, is 23 amended to read as follows: 24 (a)AAPenalty Group 2 consists of: 83R13830 JSC-F 1 C.S.H.B.ANo.A1333 1 (1)AAany quantity of the following hallucinogenic 2 substances, their salts, isomers, and salts of isomers, unless 3 specifically excepted, if the existence of these salts, isomers, 4 and salts of isomers is possible within the specific chemical 5 designation: 6 alpha-ethyltryptamine; 7 alpha-methyltryptamine; 8 5-(2-aminopropyl)benzofuran (5-APB); 9 6-(2-aminopropyl)benzofuran (6-APB); 10 5-(2-aminopropyl)-2,3-dihydrobenzofuran 11 (5-APDB); 12 6-(2-aminopropyl)-2,3-dihydrobenzofuran 13 (6-APDB); 14 5-(2-aminopropyl)indole (Trade or other names: 15 5-IT, 5-API); 16 6-(2-aminopropyl)indole (Trade or other names: 17 6-IT, 6-API); 18 Benzothiophenylcyclohexylpiperidine (BTCP); 19 4-bromo-2, 5-dimethoxyamphetamine (some trade or 20 other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine; 21 4-bromo-2, 5-DMA); 22 4-bromo-2, 5-dimethoxyphenethylamine; 23 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b ']difuran- 24 4-ethanamine (Trade or other name: Bromo-DragonFLY); 25 Bufotenine (some trade and other names: 3-(beta- 26 Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- 27 indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- 2 C.S.H.B.ANo.A1333 1 dimethyltryptamine; mappine); 2 Desoxypipradrol (2-benzhydrylpiperidine); 3 Diethyltryptamine (some trade and other names: N, 4 N-Diethyltryptamine, DET); 5 2, 5-dimethoxyamphetamine (some trade or other 6 names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); 7 2, 5-dimethoxy-4-ethylamphetamine (trade or other 8 name: DOET); 9 2, 5-dimethoxy-4-(n)-propylthiophenethylamine 10 (trade or other name: 2C-T-7); 11 Dimethyltryptamine (trade or other name: DMT); 12 Diphenylprolinol (diphenyl(pyrrolidin-2-yl) 13 methanol, D2PM); 14 Dronabinol (synthetic) in sesame oil and 15 encapsulated in a soft gelatin capsule in a U.S. Food and Drug 16 Administration approved drug product (some trade or other names for 17 Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- 18 trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- 19 (trans)- tetrahydrocannabinol); 20 Ethylamine Analog of Phencyclidine (some trade or 21 other names: N-ethyl-1-phenylcyclohexylamine, (1- 22 phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, 23 cyclohexamine, PCE); 24 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone 25 (Trade or other name: methoxetamine); 26 Ibogaine (some trade or other names: 7-Ethyl-6, 27 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- 3 C.S.H.B.ANo.A1333 1 pyrido [1 ', 2 ':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); 2 5-iodo-2-aminoindiane (5-IAI); 3 Mescaline; 4 5-methoxy-N, N-diisopropyltryptamine 5 (5-MeO-DIPT); 6 5-methoxy-N, N-diallyltryptamine (5MeO-DALT); 7 5-methoxy-3, 4-methylenedioxy amphetamine; 8 4-methoxyamphetamine (some trade or other names: 9 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; 10 PMA); 11 4-methoxymethamphetamine (PMMA); 12 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone 13 (Trade or other names: 2-MeO-ketamine; methoxyketamine); 14 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, 15 PPMP); 16 4-methyl-2, 5-dimethoxyamphetamine (some trade 17 and other names:AA4-methyl-2, 5-dimethoxy-alpha- 18 methylphenethylamine; "DOM"; "STP"); 19 3,4-methylenedioxy methamphetamine (MDMA, MDM); 20 3,4-methylenedioxy amphetamine; 21 3,4-methylenedioxy N-ethylamphetamine (Also 22 known as N-ethyl MDA); 23 5,6-methylenedioxy-2-aminoindane (MDAI); 24 Nabilone (Another name for nabilone: (+)-trans- 25 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, 26 6-dimethyl-9H-dibenzo[b,d] pyran-9-one; 27 N-benzylpiperazine (some trade or other names: 4 C.S.H.B.ANo.A1333 1 BZP; 1-benzylpiperazine); 2 N-ethyl-3-piperidyl benzilate; 3 N-hydroxy-3,4-methylenedioxyamphetamine (Also 4 known as N-hydroxy MDA); 5 4-methylaminorex; 6 N-methyl-3-piperidyl benzilate; 7 O-Acetylpsilocin (Trade or other name: 8 4-Aco-DMT); 9 Parahexyl (some trade or other names: 3-Hexyl-1- 10 hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] 11 pyran; Synhexyl); 12 1-Phenylcyclohexylamine; 13 1-Piperidinocyclohexanecarbonitrile (PCC); 14 Psilocin; 15 Psilocybin; 16 Pyrrolidine Analog of Phencyclidine (some trade 17 or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); 18 Tetrahydrocannabinols, other than marihuana, and 19 synthetic equivalents of the substances contained in the plant, or 20 in the resinous extractives of Cannabis, or synthetic substances, 21 derivatives, and their isomers with similar chemical structure and 22 pharmacological activity such as: 23 delta-1 cis or trans tetrahydrocannabinol, 24 and their optical isomers; 25 delta-6 cis or trans tetrahydrocannabinol, 26 and their optical isomers; 27 delta-3, 4 cis or trans 5 C.S.H.B.ANo.A1333 1 tetrahydrocannabinol, and its optical isomers; 2 compounds of these structures, regardless of 3 numerical designation of atomic positions, since nomenclature of 4 these substances is not internationally standardized; 5 Thiophene Analog of Phencyclidine (some trade or 6 other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl 7 Analog of Phencyclidine; TPCP, TCP); 8 1-pyrrolidine (some trade or other name: TCPy); 9 1-(3-trifluoromethylphenyl)piperazine (trade or 10 other name: TFMPP); and 11 3,4,5-trimethoxy amphetamine; 12 (2)AAPhenylacetone (some trade or other names: 13 Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl 14 ketone); 15 (3)AAunless specifically excepted or unless listed in 16 another Penalty Group, a material, compound, mixture, or 17 preparation that contains any quantity of the following substances 18 having a potential for abuse associated with a depressant or 19 stimulant effect on the central nervous system: 20 Aminorex (some trade or other names: aminoxaphen; 21 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- 22 phenyl-2-oxazolamine); 23 Amphetamine, its salts, optical isomers, and 24 salts of optical isomers; 25 Cathinone (some trade or other names: 2-amino-1- 26 phenyl-1-propanone, alpha-aminopropiophenone, 2- 27 aminopropiophenone); 6 C.S.H.B.ANo.A1333 1 Etaqualone and its salts; 2 Etorphine Hydrochloride; 3 Fenethylline and its salts; 4 Lisdexamfetamine, including its salts, isomers, 5 and salts of isomers; 6 Mecloqualone and its salts; 7 Methaqualone and its salts; 8 Methcathinone (some trade or other names: 2- 9 methylamino-propiophenone; alpha-(methylamino)propriophenone; 10 2-(methylamino)-1-phenylpropan-1-one; alpha-N- 11 methylaminopropriophenone; monomethylpropion; ephedrone, N- 12 methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 13 1431); 14 N-Ethylamphetamine, its salts, optical isomers, 15 and salts of optical isomers; and 16 N,N-dimethylamphetamine (some trade or other 17 names: N,N,alpha-trimethylbenzeneethaneamine; 18 N,N,alpha-trimethylphenethylamine), its salts, optical isomers, 19 and salts of optical isomers; and 20 (4)AAany compound structurally derived from 21 2-aminopropanal by substitution at the 1-position with any 22 monocyclic or fused-polycyclic ring system, including: 23 (A)AAcompounds further modified by: 24 (i)AAsubstitution in the ring system to any 25 extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, 26 hydroxyl, or halide substituents), whether or not further 27 substituted in the ring system by other substituents; 7 C.S.H.B.ANo.A1333 1 (ii)AAsubstitution at the 3-position with an 2 acyclic alkyl substituent; or 3 (iii)AAsubstitution at the 2-amino nitrogen 4 atom with alkyl, [or] dialkyl, benzyl, or methoxybenzyl groups, or 5 inclusion of the 2-amino nitrogen atom in a cyclic structure; and 6 (B)AAby example, compounds such as: 7 4-Methoxymethcathinone (Also known as 8 Methedrone); 9 4-Methylmethcathinone (Also known as 10 Mephedrone); 11 3,4-Dimethylmethcathinone (Also known as 12 3,4-DMMC); 13 3-Fluoromethcathinone (Also known as 3-FMC); 14 4-Fluoromethcathinone (Also known as 15 Flephedrone); 16 3,4-Methylenedioxy-N-methylcathinone (Also 17 known as Methylone); 18 3,4-Methylenedioxypyrovalerone (Also known 19 as MDPV); 20 alpha-Pyrrolidinopentiophenone (Also known 21 as alpha-PVP); 22 NaphthylpyrovaleroneAA(Also known as 23 Naphyrone); 24 beta-Keto-N-methylbenzodioxolylpropylamine 25 (Also known as Butylone); 26 beta-Keto-N-methylbenzodioxolylpentanamine 27 (Also known as Pentylone); 8 C.S.H.B.ANo.A1333 1 beta-Keto-Ethylbenzodioxolylbutanamine 2 (Also known as Eutylone); and 3 3,4-methylenedioxy-N-ethylcathinone (Also 4 known as Ethylone).
Recommended publications
  • Federal Register/Vol. 85, No. 178/Monday, September 14, 2020

    Federal Register/Vol. 85, No. 178/Monday, September 14, 2020

    Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices 56631 agreements. All non-confidential DEPARTMENT OF JUSTICE ADDRESSES: Written comments should written submissions will be available for be sent to: Drug Enforcement public inspection at the Office of the Drug Enforcement Administration Administration, Attention: DEA Federal Secretary and on EDIS. [Docket No. DEA–713] Register Representative/DPW, 8701 The Commission vote for these Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must determinations took place on September Importer of Controlled Substances Application: Cerilliant Corporation be sent to: Drug Enforcement 8, 2020. Administration, Attn: Administrator, The authority for the Commission’s AGENCY: Drug Enforcement 8701 Morrissette Drive, Springfield, determination is contained in section Administration, Justice. Virginia 22152. All request for a hearing 337 of the Tariff Act of 1930, as ACTION: Notice of application. should also be sent to: (1) Drug amended (19 U.S.C. 1337), and in Part SUMMARY: Cerilliant Corporation has Enforcement Administration, Attn: 210 of the Commission’s Rules of applied to be registered as an importer Hearing Clerk/OALJ, 8701 Morrissette Practice and Procedure (19 CFR part of basic class(es) of controlled Drive, Springfield, Virginia 22152; and 210). substance(s). Refer to Supplemental (2) Drug Enforcement Administration, Attn: DEA Federal Register By order of the Commission. Information listed below for further Representative/DPW, 8701 Morrissette Issued: September 8, 2020. drug information. DATES: Drive, Springfield, Virginia 22152. Lisa Barton, Registered bulk manufacturers of the affected basic class(es), and SUPPLEMENTARY INFORMATION: In Secretary to the Commission. applicants therefore, may file written accordance with 21 CFR 1301.34(a), this [FR Doc.
  • 2 Spice English Presentation

    2 Spice English Presentation

    Spice Spice contains no compensatory substances Специи не содержит компенсационные вещества Spice is a mix of herbs (shredded plant material) and manmade chemicals with mind-altering effects. It is often called “synthetic marijuana” because some of the chemicals in it are similar to ones in marijuana; but its effects are sometimes very different from marijuana, and frequently much stronger. It is most often labeled “Not for Human Consumption” and disguised as incense. Eliminationprocess • The synthetic agonists such as THC is fat soluble. • Probably, they are stored as THC in cell membranes. • Some of the chemicals in Spice, however, attach to those receptors more strongly than THC, which could lead to a much stronger and more unpredictable effect. • Additionally, there are many chemicals that remain unidentified in products sold as Spice and it is therefore not clear how they may affect the user. • Moreover, these chemicals are often being changed as the makers of Spice alter them to avoid the products being illegal. • To dissolve the Spice crystals Acetone is used endocannabinoids synhtetic THC cannabinoids CB1 and CB2 agonister Binds to cannabinoidreceptor CB1 CB2 - In the brain -in the immune system Decreased avtivity in the cell ____________________ Maria Ellgren Since some of the compounds have a longer toxic effects compared to naturally THC, as reported: • negative effects that often occur the day after consumption, as a general hangover , but without nausea, mentally slow, confused, distracted, impairment of long and short term memory • Other reports mention the qualitative impairment of cognitive processes and emotional functioning, like all the oxygen leaves the brain.
  • Hb 185 an Act Listing Synthetic

    Hb 185 an Act Listing Synthetic

    62nd Legislature HB0185 AN ACT LISTING SYNTHETIC MARIJUANA AND SALVIA AS DANGEROUS DRUGS; REQUIRING RULEMAKING BY THE DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES; PROVIDING PENALTIES; AMENDING SECTIONS 44-12-102, 45-9-101, 45-9-102, 45-9-110, 50-31-306, 50-31-310, AND 50-32-222, MCA; AND PROVIDING AN IMMEDIATE EFFECTIVE DATE. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA: Section 1. Section 44-12-102, MCA, is amended to read: "44-12-102. Things subject to forfeiture. (1) The following are subject to forfeiture: (a) all controlled substances that have been manufactured, distributed, prepared, cultivated, compounded, processed, or possessed in violation of Title 45, chapter 9; (b) all money, raw materials, products, and equipment of any kind that are used or intended for use in manufacturing, preparing, cultivating, compounding, processing, delivering, importing, or exporting any controlled substance in violation of Title 45, chapter 9, except items used or intended for use in connection with quantities of marijuana in amounts less than 60 grams; (c) except as provided in subsection (2)(d), all property that is used or intended for use as a container for anything enumerated in subsection (1)(a) or (1)(b); (d) except as provided in subsection (2), all conveyances, including aircraft, vehicles, and vessels, that are used or intended for use in any manner to facilitate the commission of a violation of Title 45, chapter 9; (e) all books, records, and research products and materials, including formulas, microfilm, tapes, and data,
  • Introduced B.,Byhansen, 16

    Introduced B.,Byhansen, 16

    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
  • Substances in Penalty Group Two

    Substances in Penalty Group Two

    Substances in Penalty Group Two Sec. 481.103. PENALTY GROUP 2. (a) Penalty Group 2 consists of: (1) any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, if the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: alpha-ethyltryptamine; 4-bromo-2, 5-dimethoxyamphetamine (some trade or other names: 4- bromo- 2, 5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA); 4-bromo-2, 5-dimethoxyphenethylamine; Bufotenine (some trade and other names: 3-(beta-Dimethylaminoethyl) - 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5- indolol; N, N- dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine); Diethyltryptamine (some trade and other names: N, N-Diethyltryptamine, DET); 2, 5-dimethoxyamphetamine (some trade or other names: 2, 5- dimethoxy- alpha-methylphenethylamine; 2, 5-DMA); 2, 5-dimethoxy-4-ethylamphetamine ( trade or other name : DOET); 2, 5-dimethoxy-4-(n)-propylthiophenethylamine (trade or other name: 2C-T-7); Dimethyltryptamine ( trade or other name : DMT); Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product (some trade or other names for Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-(trans)- tetrahydrocannabinol); Ethylamine Analog of Phencyclidine (some trade or other names: N- ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine,
  • 16.19.20 Nmac 1 Title 16 Occupational And

    16.19.20 Nmac 1 Title 16 Occupational And

    TITLE 16 OCCUPATIONAL AND PROFESSIONAL LICENSING CHAPTER 19 PHARMACISTS PART 20 CONTROLLED SUBSTANCES 16.19.20.1 ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy. [16.19.20.1 NMAC - Rp 16.19.20.1 NMAC, 06-26-2018] 16.19.20.2 SCOPE: All persons or entities that manufacture, distribute, dispense, administer, prescribe, deliver, analyze, or conduct research using controlled substances. [16.19.20.2 NMAC - Rp 16.19.20.2 NMAC, 06-26-2018] 16.19.20.3 STATUTORY AUTHORITY: Section 30-31-11 of the Controlled Substances Act, 30-31-1 through 30-31-42 NMSA 1978, authorizes the board of pharmacy to promulgate regulations and charge reasonable fees for the registration and control of the manufacture, distribution and dispensing of controlled substances. [16.19.20.3 NMAC - Rp 16.19.20.3 NMAC, 06-26-2018] 16.19.20.4 DURATION: Permanent. [16.19.20.4 NMAC - Rp 16.19.20.4 NMAC, 06-26-2018] 16.19.20.5 EFFECTIVE DATE: June 26, 2018, unless a different date is cited at the end of a section. [16.19.20.5 NMAC - Rp 16.19.20.5 NMAC, 06-26-2018] 16.19.20.6 OBJECTIVE: The objective of Part 20 of Chapter 19 is to protect the public health and welfare of the citizens of New Mexico by controlling and monitoring access to controlled substances and to give notice of the board’s designation of particular substances as controlled substances. [16.19.20.6 NMAC - Rp 16.19.20.6 NMAC, 06-26-2018] 16.19.20.7 DEFINITIONS: [RESERVED] [16.19.20.7 NMAC - Rp 16.19.20.7 NMAC, 06-26-2018] 16.19.20.8 REGISTRATION REQUIREMENTS: Persons required to register: A.
  • Model Scheduling New/Novel Psychoactive Substances Act (Third Edition)

    Model Scheduling New/Novel Psychoactive Substances Act (Third Edition)

    Model Scheduling New/Novel Psychoactive Substances Act (Third Edition) July 1, 2019. This project was supported by Grant No. G1799ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States Government. © 2019 NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. This document may be reproduced for non-commercial purposes with full attribution to the National Alliance for Model State Drug Laws. Please contact NAMSDL at [email protected] or (703) 229-4954 with any questions about the Model Language. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: NATIONAL ALLIANCE FOR MODEL STATE DRUG 1 LAWS, 1335 North Front Street, First Floor, Harrisburg, PA, 17102-2629. Model Scheduling New/Novel Psychoactive Substances Act (Third Edition)1 Table of Contents 3 Policy Statement and Background 5 Highlights 6 Section I – Short Title 6 Section II – Purpose 6 Section III – Synthetic Cannabinoids 13 Section IV – Substituted Cathinones 19 Section V – Substituted Phenethylamines 23 Section VI – N-benzyl Phenethylamine Compounds 25 Section VII – Substituted Tryptamines 28 Section VIII – Substituted Phenylcyclohexylamines 30 Section IX – Fentanyl Derivatives 39 Section X – Unclassified NPS 43 Appendix 1 Second edition published in September 2018; first edition published in 2014. Content in red bold first added in third edition. © 2019 NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. This document may be reproduced for non-commercial purposes with full attribution to the National Alliance for Model State Drug Laws.
  • Alcohol and Drug Abuse Subchapter 9 Regulated Drug Rule 1.0 Authority

    Alcohol and Drug Abuse Subchapter 9 Regulated Drug Rule 1.0 Authority

    Chapter 8 – Alcohol and Drug Abuse Subchapter 9 Regulated Drug Rule 1.0 Authority This rule is established under the authority of 18 V.S.A. §§ 4201 and 4202 which authorizes the Vermont Board of Health to designate regulated drugs for the protection of public health and safety. 2.0 Purpose This rule designates drugs and other chemical substances that are illegal or judged to be potentially fatal or harmful for human consumption unless prescribed and dispensed by a professional licensed to prescribe or dispense them, and used in accordance with the prescription. The rule restricts the possession of certain drugs above a specified quantity. The rule also establishes benchmark unlawful dosages for certain drugs to provide a baseline for use by prosecutors to seek enhanced penalties for possession of higher quantities of the drug in accordance with multipliers found at 18 V.S.A. § 4234. 3.0 Definitions 3.1 “Analog” means one of a group of chemical components similar in structure but different with respect to elemental composition. It can differ in one or more atoms, functional groups or substructures, which are replaced with other atoms, groups or substructures. 3.2 “Benchmark Unlawful Dosage” means the quantity of a drug commonly consumed over a twenty-four hour period for any therapeutic purpose, as established by the manufacturer of the drug. Benchmark Unlawful dosage is not a medical or pharmacologic concept with any implication for medical practice. Instead, it is a legal concept established only for the purpose of calculating penalties for improper sale, possession, or dispensing of drugs pursuant to 18 V.S.A.
  • Laws 2021, LB236, § 4

    Laws 2021, LB236, § 4

    LB236 LB236 2021 2021 LEGISLATIVE BILL 236 Approved by the Governor May 26, 2021 Introduced by Brewer, 43; Clements, 2; Erdman, 47; Slama, 1; Lindstrom, 18; Murman, 38; Halloran, 33; Hansen, B., 16; McDonnell, 5; Briese, 41; Lowe, 37; Groene, 42; Sanders, 45; Bostelman, 23; Albrecht, 17; Dorn, 30; Linehan, 39; Friesen, 34; Aguilar, 35; Gragert, 40; Kolterman, 24; Williams, 36; Brandt, 32. A BILL FOR AN ACT relating to law; to amend sections 28-1202 and 69-2436, Reissue Revised Statutes of Nebraska, and sections 28-401 and 28-405, Revised Statutes Cumulative Supplement, 2020; to redefine terms, change drug schedules, and adopt federal drug provisions under the Uniform Controlled Substances Act; to provide an exception to the offense of carrying a concealed weapon as prescribed; to define a term; to change provisions relating to renewal of a permit to carry a concealed handgun; to provide a duty for the Nebraska State Patrol; to eliminate an obsolete provision; to harmonize provisions; and to repeal the original sections. Be it enacted by the people of the State of Nebraska, Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2020, is amended to read: 28-401 As used in the Uniform Controlled Substances Act, unless the context otherwise requires: (1) Administer means to directly apply a controlled substance by injection, inhalation, ingestion, or any other means to the body of a patient or research subject; (2) Agent means an authorized person who acts on behalf of or at the direction of another person but does not include a common or contract carrier, public warehouse keeper, or employee of a carrier or warehouse keeper; (3) Administration means the Drug Enforcement Administration of the United States Department of Justice; (4) Controlled substance means a drug, biological, substance, or immediate precursor in Schedules I through V of section 28-405.
  • Model Scheduling New Novel Psychoactive Substances

    Model Scheduling New Novel Psychoactive Substances

    Model Scheduling New/Novel Psychoactive Substances Act September 2018 (original version published in 2014). This project was supported by Grant No. G1799ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States Government. © 2018. NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. This document may be reproduced for non- commercial purposes with full attribution to the National Alliance for Model State Drug Laws. Please contact Jon Woodruff at [email protected] or (703) 836-7496 with any questions about the Model Language. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: THE NATIONAL ALLIANCE 1 FOR MODEL STATE DRUG LAWS, 1335 North Front Street, First Floor, Harrisburg, PA, 17102-2629. Model Scheduling New/Novel Psychoactive Substances Act Table of Contents 3 Policy Statement and Background 5 Highlights 6 Section I – Short Title 6 Section II – Purpose 6 Section III – Synthetic Cannabinoids 12 Section IV – Substituted Cathinones 18 Section V – Substituted Phenethylamines 22 Section VI – N-benzyl Phenethylamine Compounds 24 Section VII – Substituted Tryptamines 27 Section VIII – Substituted Phenylcyclohexylamines 28 Section IX – Fentanyl Derivatives 37 Section X – Unclassified NPS © 2018. NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. This document may be reproduced for non- commercial purposes with full attribution to the National Alliance for Model State Drug Laws. Please contact Jon Woodruff at [email protected] or (703) 836-7496 with any questions about the Model Language.
  • 2021 SB 1738 by Senator Brodeur 9-01008B-21 20211738__ Page 1 of 34 CODING

    2021 SB 1738 by Senator Brodeur 9-01008B-21 20211738__ Page 1 of 34 CODING

    Florida Senate - 2021 SB 1738 By Senator Brodeur 9-01008B-21 20211738__ 1 A bill to be entitled 2 An act relating to controlled substances; amending s. 3 893.03, F.S.; excluding from Schedule I cannabis if it 4 is contained within a pharmaceutical product approved 5 by the United States Food and Drug Administration; 6 providing an effective date. 7 8 Be It Enacted by the Legislature of the State of Florida: 9 10 Section 1. Paragraph (c) of subsection (1) of section 11 893.03, Florida Statutes, is amended to read: 12 893.03 Standards and schedules.—The substances enumerated 13 in this section are controlled by this chapter. The controlled 14 substances listed or to be listed in Schedules I, II, III, IV, 15 and V are included by whatever official, common, usual, 16 chemical, trade name, or class designated. The provisions of 17 this section shall not be construed to include within any of the 18 schedules contained in this section any excluded drugs listed 19 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded 20 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical 21 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted 22 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt 23 Anabolic Steroid Products.” 24 (1) SCHEDULE I.—A substance in Schedule I has a high 25 potential for abuse and has no currently accepted medical use in 26 treatment in the United States and in its use under medical 27 supervision does not meet accepted safety standards.
  • Laws and Regulations Promulgated to Give Effect to the Provisions of the International Treaties on Narcotic Drugs and Psychotropic Substances

    Laws and Regulations Promulgated to Give Effect to the Provisions of the International Treaties on Narcotic Drugs and Psychotropic Substances

    UNITED NATIONS E/NL 1986/1-4 30 September 1986 ENGLISH ONLY * LAWS AND REGULATIONS PROMULGATED TO GIVE EFFECT TO THE PROVISIONS OF THE INTERNATIONAL TREATIES ON NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES In accordance with the relevant articles of the international treaties on narcotic drugs and psychotropic substances, the Secretary-General has the honour to communicate the following legislative texts. SWEDEN Communicated by the Government of Sweden NOTE BY THE SECRETARIAT (a) Some editing of texts may be done by the Secretariat in the interest of clarity. In this connection, words in square brackets [ ] have been added or changed by the Secretariat. (b) Only passages directly relevant to the control of narcotic drugs or psycho• tropic substances have been reproduced in this document. Non-relevant parts of laws and regulations have been deleted by the Secretariat; such deletions are indicated by [...]. INDEX PaSe E/NL.1986/1 Law Amending the Law (1960:*H8) on Penalties for the Smuggling of Goods E/NL.1986/2 Act Amending the Penal Law on Narcotics (1968:6U) 3 E/NL.1986/3 Ordinance Amending the Ordinance (1983:366) Classifying k Certain Substances as Narcotic Drugs E/NL.1986A National Board of Health and Welfare. Notification on List of Narcotics, 2 May 1985 SOSFS 1985:9 Note by the Secretariat : The present document is a direct reproduction of the texts received by the Secretariat. V.86-60352 K/NL.1986/1-4 page 2 E/NL.1986/1 SFS 1985:10 Issued by the printer's on 22 January 1985 Law amending the Law (1960:418) on Penalties for the Smuggling of Goods promulgated on 10 January 1985.